A New Chemical Entity Diperoxochloric Acid (DPOCL) Quick links. Home; Diabetic Foot Ulcer; WOXheal ®; How to use WOXheal®

Enhances cell proliferation of Fibroblasts specifically, to stimulate the healing and enforce closing of the wound. Antibacterial action: Diperoxochloric Acid Topical Solution is functionally antibacterial (especially against gram negative bacteria), which keeps the bacterial burden of open wounds low.

WOXheal ® has not been tested in pediatric patients. So, it can only be safely used in patients with diabetic foot ulcer above 18 years of age. For pregnant women, lactating women and persons below 18 years of age- Please refer Prescribing Information of "WOXheal ® " …

WOXheal | Centaur Pharmaceuticals Pvt Ltd.

Sep 30, 2020 · New Delhi: Centaur Pharmaceuticals on Tuesday annou nce d the launch of a New Chemical Entity (NCE) – WOXheal – for the first time in the world. A globally patented product, WOXheal topical solution, contains the NCE, Diperoxochloric acid, …

Oct 1, 2020 · Dr Mark-Andre Freyberg, the co-innovator of WOXheal and CEO of CytoTools AG, Germany said, “Woxheal has completed Phase III clinical trials in India and demonstrated rapid and effective wound healing in patients with diabetic foot ulcers, a condition that is notoriously difficult to treat.”

The Woxheal Solution is carefully designed to not only promote healing but also prevent complications associated with these ulcers. For patients, the uses of Woxheal are vast. It can help to minimise inflammation and pain, which are common symptoms associated with this condition.

Sep 28, 2020 · Centaur Pharmaceuticals is launching a diabetic foot ulcer treatment drug Woxheal, a New Chemical Entity (NCE) in the country. The product will be made available from October 1, 2020, across the country. The drug will cost Rs 1850 for a week’s treatment.

Sep 29, 2020 · Centaur Pharmaceuticals announced the launch of a New Chemical Entity (NCE) – WOXheal. With its dual mechanism of action, WOXheal is a unique product in diabetic foot ulcer treatment. It will save millions of people with diabetes who have to …

Oct 20, 2020 · Centaur Pharmaceuticals launched a New Chemical Entity (NCE) – WOXheal. With its dual mechanism of action, WOXheal is a unique product in the treatment of Diabetic Foot ulcers, and it will save millions of Diabetics who have to undergo foot amputation globally.